GitLab

Investment view

At $35.59, GTLB requires a 31% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 25%.

The disagreement with the market on this name is about whether ~25% growth persists, not about whether the margin arrives.

$1.1bn the year after. The house has no independent revenue forecast to bridge - the reverse DCF SOLVES rather than forecasts, and 24.90% is a trailing figure.

The conditions that would settle the disagreement are dated 5y (to FY2031).

The value rests on an exit multiple of 10.9x, a terminal operating margin of 16% and a 10.2% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: the Duo Agent Platform inflects GitLab's cost structure without inflecting its pricing.

Underwriting bridge

What must go right

1. By every 10-Q and 10-K, MD&A 'Key Business Metrics - Dollar-Based Net Retention Rate and ARR'Dollar-Based Net Retention Rate is disclosed at or above 110% in any quarterWhere it stands: Dollar-Based Net Retention Rate
2. By quarterly income statement, every 10-Q and 10-KGross margin at or above 82.0% in two consecutive quartersWhere it stands: quarterly GAAP gross margin
3. By quarterly, computed TTM vs prior-TTM from the filed income statementsThe condition does not occur: Total operating expenses grow faster than revenue on a TTM-versus-prior-TTM basis in two consecutive quartersWhere it stands: change in TTM GAAP operating margin vs prior-TTM

Catalysts and falsifiers

Risk and sell discipline

Impairment case

The Duo Agent Platform inflects GitLab's cost structure without inflecting its pricing. Cost of revenue is compounding at +49.7% YoY against revenue at +23.1%; gross margin has fallen 88.33% -> 85.81% on the quarter and 88.64% -> 86.74% on TTM, four consecutive quarters, and the company itself warns that as SaaS and Duo grow as a share of revenue it expects increased cloud costs which 'may adversely impact our gross margins'. Simultaneously Dollar-Based Net Retention fell 122% -> 117% (30 April 2026 vs 30 April 2025) while base customers grew only +7% (10,104 -> 10,831), so the growth is expansion inside a slowly-growing account base. Consensus already underwrites the deceleration: FY2027 revenue $1,116.9m (n=26) is +16.9%, with the implied Q4 FY2027 at +14.4% YoY. WHY THIS IS AN IMPAIRMENT CASE AND not A VALUATION BEAR CASE: it is not 'the multiple compresses'.

Estimated probability 20%, against the 21% level at which the position would be resized. It sits within that level.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

• Dollar-Based Net Retention Rate is disclosed below 110% in any quarterDollar-Based Net Retention Rate · every 10-Q and 10-K, MD&A 'Key Business Metrics - Dollar-Based Net Retention Rate and ARR'
• Gross margin below 82.0% in two consecutive quartersquarterly GAAP gross margin · quarterly income statement, every 10-Q and 10-K
• Total operating expenses grow faster than revenue on a TTM-versus-prior-TTM basis in two consecutive quarterschange in TTM GAAP operating margin vs prior-TTM · quarterly, computed TTM vs prior-TTM from the filed income statements
• Remaining performance obligations grow below +10% YoY in any quarter, or the share of RPO expected to be recognised within 12 months falls below 60%RPO YoY growth; 12-month recognisable share of RPO · quarterly, revenue note ('Remaining Performance Obligations') in every 10-Q and 10-K

Price-based risk trigger

Upside sell discipline

On approach to the $41.01 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The gap between what today's price requires and what the business has demonstrated is -6.4 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is whether the operating path today's price requires is achievable; the evidence does not settle it. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $29.29, which forces an immediate review.